Helius Medical Technologies Inc (HSDT) saw an uptrend of 141.67% in the recent trading with $18.27 being its most recent. The current price level -98.48% lower than the highest price of $1200.00 marked by the stock while trading over the past 52-weeks, whereas it is 240.22% higher than the lowest price of $5.37 the company dropped to over past 52-weeks. The latest news story on HSDT appeared in (99bitcoins) under the title “Experts Call For $500 SOL USD: Corporate Treasuries Bid as Solana Signals Breakout”.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Strong Buy by 3 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.00 for the stock.
Helius Medical Technologies Inc Earnings – What Happened With HSDT
Coming around sales and income figures on HSDT Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor. Helius Medical Technologies Inc (HSDT) last released financial results for the quarter that ended 9/30/2024, posting a surprise factor of 3.21% for net revenue.
HSDT – Helius Medical Technologies Inc Stock Earnings Estimates
The perspective of Helius Medical Technologies Inc (NASDAQ:HSDT)’s current quarter earnings identifies that analysts are in consensus over the estimate of -795 for stock’s EPS in the current quarter. Helius Medical Technologies Inc (HSDT) last released financial results for the quarter that ended 9/30/2024, posting a surprise factor of 3.21% for net revenue. Company’s EPS for the last quarter was -769.5.
Helius Medical Technologies Inc – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 1.08 million. HSDT does have institutional investors; and they hold 1.14% of the stock.
Key Metrics for HSDT
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Helius Medical Technologies Inc has a debt to equity ratio of 0.00.
